SMAD2 and neoplasm: In fibroblasts, SMAD2/3 not only differentially regulate fibrosis and response to antifibrotic drugs [9, 14] but they may also control cell migration, which may be relevant for the formation of the fibrotic tumour microenvironment (TME).